![Martinus Adrianus van Osch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martinus Adrianus van Osch
Fondateur chez
Forbion Capital Partners Management Holding BV
Profil
Martinus Adrianus van Osch founded Forbion Capital Partners Management Holding BV in 2007, where he is working as Managing Partner from 2007.
Mr. van Osch also currently works at Mitralign, Inc., as Director, FlowMedica, Inc., as Director, Autonomic Technologies, Inc., as Director, and X-Cell Medical, Inc., as Director.
Mr. van Osch also formerly worked at ACADIA Pharmaceuticals, Inc., as Director, PneumRx LLC, as Director, CircuLite, Inc., as Director, Cambridge Drug Discovery Holdings Ltd., as Director, Pathway Medical Technologies, Inc., as Director, and Roche Innovation Center Copenhagen A, as Director.
Mr. van Osch received his graduate degree from the University of Groningen.
Postes actifs de Martinus Adrianus van Osch
| Sociétés | Poste | Début |
|---|---|---|
X-Cell Medical, Inc.
 X-Cell Medical, Inc. Medical SpecialtiesHealth Technology Develops drugs for cardiovascular clinical applications | Directeur/Membre du Conseil | - |
FlowMedica, Inc.
 FlowMedica, Inc. Medical SpecialtiesHealth Technology Develops intravascular systems and medical devices | Directeur/Membre du Conseil | - |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Fondateur | 08/01/2007 |
Autonomic Technologies, Inc.
 Autonomic Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for the treatment of severe headache autonomic disorder | Directeur/Membre du Conseil | - |
Anciens postes connus de Martinus Adrianus van Osch
| Sociétés | Poste | Fin |
|---|---|---|
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Directeur/Membre du Conseil | 02/09/2014 |
| ACADIA PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 09/09/2005 |
Cambridge Drug Discovery Holdings Ltd.
 Cambridge Drug Discovery Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Researches potential new drugs for the treatment of cancer | Directeur/Membre du Conseil | - |
PneumRx LLC
 PneumRx LLC Medical SpecialtiesHealth Technology Operates as a medical device company which focuses on developing minimally-invasive solutions for unmet medical needs in pulmonary medicine | Directeur/Membre du Conseil | - |
Pathway Medical Technologies, Inc.
 Pathway Medical Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures, develops and markets medical devices for treatment of arterial disease | Directeur/Membre du Conseil | - |
Formation de Martinus Adrianus van Osch
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
31
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Mitralign, Inc.
 Mitralign, Inc. Medical SpecialtiesHealth Technology Engages in the development of medical devices | Health Technology |
FlowMedica, Inc.
FlowMedica, Inc. Medical SpecialtiesHealth Technology Develops intravascular systems and medical devices | Health Technology |
PneumRx LLC
PneumRx LLC Medical SpecialtiesHealth Technology Operates as a medical device company which focuses on developing minimally-invasive solutions for unmet medical needs in pulmonary medicine | Health Technology |
CircuLite, Inc.
 CircuLite, Inc. Medical DistributorsDistribution Services Provides treatment for heart disorders | Distribution Services |
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for the treatment of severe headache autonomic disorder | Health Technology |
Cambridge Drug Discovery Holdings Ltd.
Cambridge Drug Discovery Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Researches potential new drugs for the treatment of cancer | Commercial Services |
Pathway Medical Technologies, Inc.
Pathway Medical Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures, develops and markets medical devices for treatment of arterial disease | Health Technology |
X-Cell Medical, Inc.
X-Cell Medical, Inc. Medical SpecialtiesHealth Technology Develops drugs for cardiovascular clinical applications | Health Technology |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Health Technology |
University of Groningen
 University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Finance |
